Good science behind hepatitis C virus antiviral drug development: necessary but not sufficient.
Pappas
S Chris
SC
D000998:Antiviral Agents / Q000627:therapeutic use*; D015195:Drug Design; D004341:Drug Evaluation / Q000191:economics; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D051217:Toll-Like Receptor 9 / Q000819:agonists
D000998:Antiviral Agents; D051217:Toll-Like Receptor 9